Clayton Utz

Intellectual Property Department

Current View:

This content is provided by Chambers. Learn more about our methodology

What the team is known for Offers broad-based IP expertise including trade mark and copyright protection, with frequent involvement in cases featuring an international element. Handles complex patent matters for a diverse clientele, most notably in the pharmaceutical, technology and telecoms sectors. Active in both contentious and non-contentious matters, though particularly strong on disputes, offering significant expertise in design infringement, passing off and misleading conduct cases.

Strengths Clients value the department's "deep knowledge" and "strong client care," with one client emphasising its ability to "provide the right balance, give very considered and fast advice, be very commercial, and always look for different angles and alternatives."

Another client describes the team as "patient, commercial, knowledgeable, outcome-oriented, and professional."

Work highlights Acted for Novartis to enforce a range of second-generation patents with a view to preventing the entry of generic competition for the blockbuster multiple sclerosis drug Gilenya.

Notable practitioners

John Collins
"is very good to work with; he gives strategic and commercial advice," says a client, who goes on to add: "He's very thoughtful and responsive." Collins is highly experienced in patent litigation, acts for clients in a variety of sectors and offers notable expertise in high-profile pharmaceutical cases.

Timothy Webb
is praised by clients for his "practical advice," with one client specifying that he is "very adept at breaking down complex issues into easy-to-understand concepts, proactive in his thinking around strategy, extremely responsive, and he understands issues from the client's perspective." Another client highlights his "expert technical legal as well as commercial ability and his eye for detail, which exceeds expectations." He is regularly instructed by a wide range of clients on various contentious copyright and trade mark matters.